This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient on penicillamine therapy should be told that the treatment: 1. will resolve her ... (Read 79 times)

ashley

  • Hero Member
  • *****
  • Posts: 584
on: Jul 23, 2018
A patient on penicillamine therapy should be told that the treatment:
 
  1. will resolve her symptoms of rheumatoid arthritis.
  2. will halt the progression of the disease.
  3. may slow or halt the progression of the disease.
  4. is a cure for arthritis.

Question 2

The patient is an energetic 4-year-old who has had asthma since birth. He takes theophylline regularly. When he comes in, the doctor will be most concerned about:
 
  1. the presence of infection and bronchospasm.
  2. his blood theophylline levels.
  3. his ability to swallow the medication.
  4. adverse reactions.


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

chereeb

  • Sr. Member
  • ****
  • Posts: 326
Reply #1 on: Jul 23, 2018
Answer to Question 1

3
Penicillamine is known to be effective in relieving the symptoms of arthritis and in some ways stops the disease progression.

Answer to Question 2

4
Adverse reactions to sympathomimetic bronchodilators include symptoms related to stimulation of alpha and beta receptors throughout the body.


ashley

  • Hero Member
  • *****
  • Posts: 584
Reply #2 on: Jul 23, 2018
TY


chereeb

  • Sr. Member
  • ****
  • Posts: 326
Reply #3 on: Jul 23, 2018
You're welcome


« previous next »
 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Gene Therapy Gene Therapy
When using an interpreter, the nurse should pose questions directly to the patient, not the interpre When using an interpreter, the nurse should pose questions directly to the patient, not the interpre
Symptoms of a patient in shock. Symptoms of a patient in shock.
Patient teaching: female breast assessment Patient teaching: female breast assessment
Instructing the Patient in Collecting a Stool Specimen Instructing the Patient in Collecting a Stool Specimen
A pacemaker in a patient’s chest. A pacemaker in a patient’s chest.
Video: Structure of Amino Acid, Peptide Bonds & Polypeptides

For a complete list of videos, visit our video library